Khabre branded placeholder image

science

Scientists are mapping the many ways cells can die

Modern gene editing, high-resolution imaging and omics tools have expanded cell biology beyond the two classic forms of cell death. Researchers are also finding that some cells can delay death or recover after a death programme begins.

Khabre branded placeholder image

health

Nature Medicine flags data concerns in 2015 EZH2 cancer study

Nature Medicine has issued an Editorial Expression of Concern about a 2015 letter on EZH2 dependence in SWI/SNF-mutant cancers. The notice identifies similarities in several figure panels and says the original data are no longer available.

Khabre branded placeholder image

science

Preprint maps how replication stress changes DNA-break locations in cancer cells

A bioRxiv preprint integrates genome-wide maps of DNA breaks, replication and transcription in U2-OS and HeLa cancer cell lines. It reports that prolonged low-dose DNA polymerase inhibition redirects breaks toward late-replicating regions and identifies MUS81 as a regulator of recurrent break clusters.

Khabre branded placeholder image

science

Drugs mimicking GABAergic signalling slow glioma growth in mice

An investigation has found that drugs mimicking the effect of GABAergic neurons slowed glioma growth in mice. The result points to a possible way of targeting interactions between neurons and nervous-system cancer, but remains preclinical.

Khabre branded placeholder image

health

Preprint associates gut microbiome score with cancer risk years before diagnosis

A medRxiv preprint reports that a risk score based on 28 gut microbial species was associated with cancer diagnoses during up to 10 years of follow-up. The finding comes from an observational analysis and represents a candidate biomarker for future validation, not a clinical screening test.